MyBCTeam

Breast cancers can vary in their hormone receptor status, even within the same breast. The estrogen receptor (ER) status helps determine how the cancer might respond to hormone therapy and affects treatment planning.

ER-positive breast cancers can behave differently - some may respond strongly to estrogen while others have Show Full Answer

Breast cancers can vary in their hormone receptor status, even within the same breast. The estrogen receptor (ER) status helps determine how the cancer might respond to hormone therapy and affects treatment planning.

ER-positive breast cancers can behave differently - some may respond strongly to estrogen while others have a weaker response. This is why comprehensive testing is important for developing the most effective treatment plan. It's important to note that ER-positive breast cancers have different patterns of recurrence compared to ER-negative cancers. ER-positive cancers are more likely to recur later (10+ years after treatment), while ER-negative cancers tend to recur earlier (within 5 years of treatment).

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Stage 1 HER2-Positive Breast Cancer: Treatment, Survival Rates, and Other Facts

Which Types of Breast Cancer Have the Highest Recurrence Rates?